StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
70
This month
2
This year
16
Publishing Date
2024 - 02 - 12
2
2024 - 01 - 29
1
2024 - 01 - 26
1
2024 - 01 - 17
2
2024 - 01 - 10
1
2024 - 01 - 09
1
2024 - 01 - 08
1
2023 - 12 - 08
1
2023 - 12 - 04
1
2023 - 11 - 27
1
2023 - 10 - 31
1
2023 - 10 - 30
1
2023 - 10 - 26
1
2023 - 10 - 20
1
2023 - 10 - 17
1
2023 - 10 - 11
1
2023 - 10 - 03
1
2023 - 09 - 26
1
2023 - 09 - 15
1
2023 - 08 - 15
1
2023 - 08 - 08
1
2023 - 07 - 31
1
2023 - 07 - 27
1
2023 - 07 - 14
1
2023 - 06 - 28
1
2023 - 06 - 13
1
2023 - 05 - 24
1
2023 - 05 - 03
1
2023 - 04 - 25
1
2023 - 04 - 18
1
2023 - 04 - 14
1
2023 - 04 - 12
1
2023 - 04 - 11
1
2023 - 03 - 20
1
2023 - 03 - 10
1
2023 - 02 - 02
1
2023 - 01 - 09
1
2023 - 01 - 03
1
2022 - 12 - 08
1
2022 - 11 - 28
1
2022 - 10 - 14
1
2022 - 10 - 05
1
2022 - 10 - 04
2
2022 - 09 - 28
1
2022 - 09 - 15
1
2022 - 09 - 05
1
2022 - 08 - 05
1
2022 - 06 - 24
1
2022 - 05 - 23
1
2022 - 05 - 02
1
2022 - 04 - 25
1
2022 - 04 - 21
1
2022 - 04 - 12
1
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 02 - 22
1
2021 - 12 - 16
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 10 - 06
1
Sector
Health services
1
Health technology
70
Information
1
Manufacturing
70
N/a
15
Producer manufacturing
1
Tags
Abbvie
1
Active
1
America
8
Antibiotics
1
Asia
1
Astrazeneca
1
Biotech
2
Blood
1
Cancer
8
Cancer drug
1
Cel
1
Cell
1
Companies
4
Dermatitis
3
Device
1
Diagnostics
1
Disease
6
Disorders
1
Drug
6
Europe
1
Expansion
1
Expected
4
Financial
1
Funding
1
Global
12
Growing
3
Growth
25
Infections
2
Key
1
Kidney
2
Leukemia
2
Liver
2
Lung
3
Lung cancer
1
Market
55
Million
2
N/a
69
Nervous system
1
Order
1
Pharm-country
1
Pharma
6
Plus
1
Pneumococcal
1
Positive
1
Potential
2
Rare
1
Reach
5
Renal
1
Report
12
Research
11
Results
1
Roche
1
Set
1
Study
1
System
2
Therapeutics
11
Therapy
1
Treatment
10
Trends
1
Vaccine
6
Entities
Abbott laboratories
222
Abbvie inc.
167
Alnylam pharmaceuticals, inc.
63
Alphabet inc.
37
Amarin corporation plc
36
Amgen inc.
132
Astellas pharma inc
70
Astrazeneca plc
177
Bausch health companies inc.
24
Baxter international inc.
41
Becton, dickinson and company
26
Biogen inc.
48
Biomarin pharmaceutical inc.
19
Biontech se
129
Boston scientific corporation
19
Bristol-myers squibb company
70
Byline bancorp, inc.
26
Csl ltd
22
Denali therapeutics inc.
19
Eli lilly and company
253
Endo international plc
18
Galapagos nv
41
Gilead sciences, inc.
35
Glaxosmithkline plc
273
Icon plc
12
Igm biosciences, inc.
37
Incyte corporation
102
Innate pharma s.a.
81
Innate pharma sa
81
Insulet corporation
15
Johnson & johnson
467
Kymera therapeutics, inc.
22
Medtronic plc
33
Mobiv acquisition corp
65
Moderna, inc.
22
Morgan stanley
14
Morphosys ag
38
Nektar therapeutics
44
Novartis ag
285
Novo nordisk a/s
100
Nurix therapeutics, inc.
14
Oncocyte corporation
37
Orange
49
Pegasus digital mobility acquisition corp.
17
Perrigo company
105
Pfizer, inc.
90
Provention bio, inc.
283
Ptc therapeutics, inc.
35
Rallybio corp
36
Rcf acquisition corp.
83
Reckitt benckiser group plc
21
Regeneron pharmaceuticals, inc.
190
Sanofi
3618
Takeda pharmaceutical company limited
51
Teva pharmaceutical industries limited
17
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
35
Thermo fisher scientific inc
36
Vaxart, inc.
36
Viatris inc.
81
Symbols
ABBV
49
ABEO
7
ABT
21
ADAP
7
ADXS
2
AFMD
2
ALNY
2
ALPMF
334
ALPMY
334
AMGN
31
APVO
2
AZN
42
AZNCF
42
BAX
4
BCLI
5
BHC
6
BIIB
11
BMY
11
BNTX
5
CLYYF
4
CMXHF
12
CSLLY
12
ENDP
4
ENDPQ
3
EPIX
4
FGEN
3
FNCTF
3
GBIO
6
GILD
3
GLAXF
48
GSK
48
INCY
6
IONS
3
ISEE
10
JAZZ
4
JNJ
26
LLY
25
MDT
3
MEOBF
6
MNK
7
MNKKQ
6
MNKPF
4
MRK
4
MTLHF
3
MTLHY
3
NVO
3
NVS
70
NVSEF
70
ORTX
7
PFE
26
SGEN
20
SNY
70
SNYNF
70
TAK
14
TEVJF
27
TMO
4
TWST
3
UCBJF
4
UCBJY
4
VTRS
22
Exchanges
Amex
1
Nasdaq
70
Nyse
63
Crawled Date
2024 - 02 - 12
2
2024 - 01 - 29
1
2024 - 01 - 27
1
2024 - 01 - 17
2
2024 - 01 - 10
1
2024 - 01 - 09
1
2024 - 01 - 08
1
2023 - 12 - 08
1
2023 - 12 - 04
1
2023 - 11 - 27
1
2023 - 10 - 31
1
2023 - 10 - 30
1
2023 - 10 - 26
1
2023 - 10 - 20
1
2023 - 10 - 17
1
2023 - 10 - 11
1
2023 - 10 - 03
1
2023 - 09 - 26
1
2023 - 09 - 15
1
2023 - 08 - 15
1
2023 - 08 - 08
1
2023 - 07 - 31
1
2023 - 07 - 27
1
2023 - 07 - 14
1
2023 - 06 - 28
1
2023 - 06 - 13
1
2023 - 05 - 24
1
2023 - 05 - 03
1
2023 - 04 - 25
1
2023 - 04 - 18
1
2023 - 04 - 14
1
2023 - 04 - 12
1
2023 - 04 - 11
1
2023 - 03 - 20
1
2023 - 03 - 10
1
2023 - 02 - 02
1
2023 - 01 - 09
1
2023 - 01 - 03
1
2022 - 12 - 08
1
2022 - 11 - 28
1
2022 - 10 - 14
1
2022 - 10 - 05
1
2022 - 10 - 04
2
2022 - 09 - 28
1
2022 - 09 - 15
1
2022 - 09 - 05
1
2022 - 08 - 05
1
2022 - 06 - 24
1
2022 - 05 - 23
1
2022 - 05 - 02
1
2022 - 04 - 25
1
2022 - 04 - 21
1
2022 - 04 - 12
1
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 02 - 22
1
2021 - 12 - 16
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 10 - 06
1
Crawled Time
00:00
1
00:20
1
01:00
2
02:00
2
03:00
2
04:00
1
05:00
5
06:00
1
07:00
2
08:00
5
09:00
5
10:00
2
11:00
4
12:00
1
13:00
1
13:30
1
14:00
2
14:30
1
15:00
5
15:30
1
16:00
3
18:00
5
19:00
5
20:00
3
21:00
4
22:00
2
23:00
3
Source
www.biospace.com
1
www.prnewswire.com
69
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Astellas pharma inc
symbols :
Snynf
save search
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published:
2024-04-17
(Crawled : 09:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
2.32%
|
O:
0.12%
H:
0.51%
C:
0.51%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
3.17%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.59%
|
O:
1.05%
H:
0.0%
C:
0.0%
treatment
global
growth
market
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-11.83%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.01%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.31%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-9.36%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.07%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
-4.03%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.33%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.99%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$108.38
-1.18%
-1.19%
400K
|
Health Technology
|
-5.16%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published:
2024-03-11
(Crawled : 14:30)
- prnewswire.com
CMXHF
|
$176.0
-19.21%
50
|
n/a
|
-4.86%
|
O:
0.41%
H:
0.0%
C:
0.0%
CSLLY
|
$90.71
3.3%
35K
|
n/a
|
-3.75%
|
O:
-4.92%
H:
3.76%
C:
3.44%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-8.99%
|
O:
-3.4%
H:
1.49%
C:
1.49%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
7.0%
|
O:
1.55%
H:
0.82%
C:
0.16%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-10.64%
|
O:
-1.41%
H:
5.06%
C:
4.01%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-4.4%
|
O:
-0.6%
H:
0.19%
C:
0.09%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-10.93%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-2.08%
|
O:
0.57%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
6.54%
|
O:
1.08%
H:
0.82%
C:
0.67%
pharma
vaccine
astrazeneca
research
key
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-8.95%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-1.52%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
10.47%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-5.82%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
28.21%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-14.66%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-9.46%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.61%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-1.67%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
-0.92%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-3.77%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-3.85%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.15%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
8.85%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-3.5%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-4.81%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
16.27%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.74%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.66%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.43%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
0.41%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
0.24%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.66
3.57%
3.45%
430K
|
Health Technology
|
-16.97%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$400.66
-1.05%
-1.06%
810K
|
Health Technology
|
-3.25%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.47
4.22%
4.05%
690
|
Health Technology
|
-8.14%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-10.7%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-21.07%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
15.37%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.0
-0.02%
-0.02%
200K
|
Health Technology
|
-4.49%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-7.1%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-9.97%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
-13.74%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-13.24%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
12.24%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-7.06%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-11.56%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-4.53%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-2.47%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-2.8%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.1%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
11.54%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-14.57%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
4.83%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-6.68%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
39.56%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-12.86%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-5.76%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.7%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-3.9%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
4.83%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-0.55%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-0.87%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
$400.66
-1.05%
-1.06%
810K
|
Health Technology
|
-2.7%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.14%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$108.38
-1.18%
-1.19%
400K
|
Health Technology
|
-12.06%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
5.68%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-13.46%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published:
2024-01-30
(Crawled : 23:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-17.75%
|
O:
4.34%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
1.27%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
6.9%
|
O:
3.41%
H:
0.0%
C:
-2.45%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-17.98%
|
O:
0.0%
H:
1.38%
C:
0.26%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.81%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.25%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
5.5%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
2.8%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-6.39%
|
O:
1.75%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
5.43%
|
O:
0.82%
H:
0.12%
C:
-1.64%
market
Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published:
2024-01-29
(Crawled : 18:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-16.3%
|
O:
1.76%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
3.03%
|
O:
2.93%
H:
0.0%
C:
-1.15%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-18.19%
|
O:
-3.53%
H:
3.49%
C:
3.4%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.42%
|
O:
-0.59%
H:
0.49%
C:
0.41%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
5.58%
|
O:
0.26%
H:
0.13%
C:
-0.18%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
3.43%
|
O:
0.19%
H:
0.46%
C:
0.43%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-6.27%
|
O:
0.12%
H:
0.0%
C:
0.0%
kidney
renal
expected
million
therapeutics
growth
market
Global Pompe Disease Drugs Market: USD 294.7 Million Growth Forecasted at a CAGR of 4.16% between 2024 to 2028 - Technavio
Published:
2024-01-26
(Crawled : 00:20)
- prnewswire.com
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
Email alert
Add to watchlist
disease
million
global
growth
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published:
2024-01-17
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-7.6%
|
O:
0.1%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
4.7%
|
O:
1.06%
H:
0.0%
C:
-2.34%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-10.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-19.1%
|
O:
-0.6%
H:
0.34%
C:
0.34%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.68%
|
O:
-0.78%
H:
0.59%
C:
0.57%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-6.62%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
4.63%
|
O:
-0.54%
H:
1.55%
C:
1.33%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.87%
|
O:
-1.1%
H:
1.63%
C:
1.59%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
6.94%
|
O:
-0.51%
H:
1.33%
C:
0.93%
report
reach
research
global
growth
market
Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published:
2024-01-17
(Crawled : 06:00)
- prnewswire.com
CSLLY
|
$90.71
3.3%
35K
|
n/a
|
-3.14%
|
O:
-0.64%
H:
0.54%
C:
0.54%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-0.26%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-9.29%
|
O:
-1.83%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.57%
|
O:
-1.74%
H:
0.0%
C:
-1.35%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.2%
|
O:
0.49%
H:
0.18%
C:
0.04%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
3.41%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
4.65%
|
O:
-0.15%
H:
0.74%
C:
0.18%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.92%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
therapeutics
market
Nontuberculous Mycobacterial Infections Market size to grow by USD 4.33 billion from 2023 to 2028, North America to account for 40% of market growth- Technavio
Published:
2024-01-10
(Crawled : 05:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.2%
|
O:
1.19%
H:
0.2%
C:
0.03%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-2.07%
|
O:
-0.09%
H:
7.77%
C:
4.4%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-4.16%
|
O:
0.76%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.34%
|
O:
0.13%
H:
0.0%
C:
0.0%
america
infections
market
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published:
2024-01-09
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-23.14%
|
O:
0.16%
H:
0.0%
C:
-3.88%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-9.65%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.72%
|
O:
-1.22%
H:
0.0%
C:
-0.72%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-7.68%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.67%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-12.01%
|
O:
-0.92%
H:
0.63%
C:
-0.25%
america
cancer
treatment
market
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Published:
2024-01-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-23.73%
|
O:
-0.85%
H:
1.05%
C:
0.08%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-7.14%
|
O:
2.07%
H:
0.48%
C:
0.48%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.96%
|
O:
0.53%
H:
3.97%
C:
0.45%
CLVT
|
$7.11
-0.42%
0.0%
2.1M
|
Information
|
-17.53%
|
O:
0.92%
H:
6.4%
C:
5.03%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-6.75%
|
O:
0.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
19.48%
|
O:
0.63%
H:
0.58%
C:
0.58%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-7.62%
|
O:
1.16%
H:
0.0%
C:
0.0%
CALT
|
$18.5
1.65%
1.62%
1.5K
|
Health Technology
|
-23.35%
|
O:
2.68%
H:
3.22%
C:
0.35%
report
potential
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-23.05%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
4.05%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.59%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-5.22%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
32.88%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.05%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.05%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
25.99%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-2.33%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.72%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.93%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-14.12%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.82%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published:
2023-12-04
(Crawled : 18:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-19.35%
|
O:
0.26%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
6.2%
|
O:
-2.6%
H:
1.1%
C:
-1.18%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
0.37%
|
O:
0.27%
H:
0.12%
C:
0.12%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-1.99%
|
O:
-1.1%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.57%
|
O:
0.0%
H:
0.5%
C:
0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.13%
|
O:
-1.86%
H:
0.34%
C:
-0.19%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
12.59%
|
O:
-1.01%
H:
0.39%
C:
0.19%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
18.24%
|
O:
0.51%
H:
0.68%
C:
0.32%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.59%
|
O:
-0.5%
H:
0.0%
C:
0.0%
GLMD
|
$0.3852
6.59%
6.18%
52K
|
Health Technology
|
-7.67%
|
O:
0.03%
H:
2.44%
C:
-1.03%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.37%
|
O:
-0.25%
H:
0.05%
C:
-0.37%
america
market
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published:
2023-11-27
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.64%
|
O:
-1.89%
H:
0.02%
C:
0.02%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.59%
|
O:
-4.49%
H:
6.23%
C:
3.42%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
21.63%
|
O:
-0.21%
H:
0.21%
C:
-1.93%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-5.15%
|
O:
-0.07%
H:
0.28%
C:
0.21%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
4.75%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
VNDA
|
$4.57
-1.3%
-1.31%
1.5M
|
Health Technology
|
30.06%
|
O:
2.81%
H:
0.0%
C:
-3.01%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.24%
|
O:
-1.41%
H:
0.87%
C:
0.0%
america
therapeutics
growth
market
Primary Sclerosing Cholangitis Market to Grow at a Tremendous CAGR of 17.2% During the Study Period (2019-2032) | DelveInsight
Published:
2023-10-31
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
5.47%
|
O:
0.94%
H:
2.55%
C:
2.55%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-25.22%
|
O:
-4.18%
H:
0.49%
C:
-0.02%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
30.05%
|
O:
-2.76%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
3.29%
|
O:
0.18%
H:
0.0%
C:
0.0%
PLRX
|
$11.88
-5.11%
-5.39%
370K
|
Health Technology
|
-14.66%
|
O:
-0.2%
H:
3.45%
C:
1.37%
CALT
|
$18.5
1.65%
1.62%
1.5K
|
Health Technology
|
11.66%
|
O:
-2.27%
H:
2.01%
C:
0.44%
study
market
← Previous
1
2
3
4
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.